Portfolio company
BigHat Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
5 investors
Sectors
About
BigHat Biosciences develops machine learning-designed antibody therapeutics for pharmaceutical partners and patients in oncology and immunology.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Nabla Bio
This company develops generative artificial intelligence and high-throughput screening platforms to design therapeutic antibodies for pharmaceutical and biotechnology partners.
LabGenius
This biopharmaceutical company develops therapeutic antibodies using an automated protein engineering platform for pharmaceutical and biotechnology partners.
Computational drug discovery platform
This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.
Abalone Bio
This company develops functional antibody drugs for pharmaceutical partners using synthetic biology and machine learning to treat challenging diseases.
Metaphore Biotechnologies
This biotechnology company develops an artificial intelligence platform to design functional antibody medicines for pharmaceutical partners and patients with autoimmune, metabolic or oncology conditions.
Generate Biomedicine
This company develops protein-based therapeutics using a generative artificial intelligence platform for pharmaceutical partners and biotechnology firms.
Xaira
The company develops artificial intelligence platforms to design and develop antibody-based medicines for patients with various diseases.
Absci
This biopharmaceutical company uses generative artificial intelligence to design and develop biologic medicines for pharmaceutical partners and clinical patients.